B. 1. Scott, W. Howington, J. Feigenberg, S. Movsas, B. Pisters et al., Treatment of Non-small Cell Lung Cancer Stage I and Stage II, Chest, vol.132, issue.3, pp.234-242, 2007.
DOI : 10.1378/chest.07-1378

C. Mountain, Revisions in the International System for Staging Lung Cancer, Chest, vol.111, issue.6, pp.1710-1717, 1997.
DOI : 10.1378/chest.111.6.1710

T. De-baère, Destruction par??radiofr??quence des??tumeurs pulmonaires et??osseuses, Cancer/Radioth??rapie, vol.10, issue.6-7
DOI : 10.1016/j.canrad.2006.07.014

F. Mellot, S. Friard, H. Doubre, A. Guth, A. Chapelier et al., Le traitement par radiofr??quence des tumeurs pulmonaires, Revue de Pneumologie Clinique, vol.67, issue.4, pp.238-281, 2011.
DOI : 10.1016/j.pneumo.2011.04.003

C. Haasbeek, S. Senan, E. Smit, M. Paul, B. Slotman et al., Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. The Oncologist, pp.309-328, 2008.

S. Spiro and J. Porter, Lung Cancer???Where Are We Today?, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.9, pp.1166-96, 2002.
DOI : 10.1164/rccm.200202-070SO

A. Jemal, F. Bray, M. Center, J. Ferlay, E. Ward et al., Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.82, issue.19 suppl, pp.69-90, 2011.
DOI : 10.3322/caac.20107

. Inca, Recommandations professionnelles Cancer du poumon non à petites cellules

A. Alberg, M. Brock, J. Ford, J. Samet, and S. Spivack, Epidemiology of Lung Cancer, Chest, vol.143, issue.5, pp.1-29, 2013.
DOI : 10.1378/chest.12-2345

D. Antoni, I. Srour, G. Noël, and F. Mornex, Radiothérapie en conditions stéréotaxiques des tumeurs broncho-pulmonaires. Cancer/Radiothérapie, pp.297-307, 2014.

A. Alberg, R. Yung, and P. Strickland, Respiratory cancer and exposure to arsenic, chromium, nickel, and polycyclic aromatic hydrocarbons, Clinics in Occupational and Environmental Medicine, vol.2, issue.4, pp.779-801, 2002.
DOI : 10.1016/S1526-0046(02)00056-0

W. Foulkes, Inherited Susceptibility to Common Cancers, New England Journal of Medicine, vol.359, issue.20, pp.2143-53, 2008.
DOI : 10.1056/NEJMra0802968

. Natl-cancer-inst, P. Grosclaude, N. Bossard, E. Jougla, E. Benhamou et al., Cancer incidence and mortality in France over the period, Rev Epidemiol Sante Publique, vol.56, pp.159-75, 1980.

J. Jett, S. Schild, K. Kesler, and G. Kalemkerian, Treatment of Small Cell Lung Cancer, Chest, vol.143, issue.5, pp.400-419, 2013.
DOI : 10.1378/chest.12-2363

F. Detterbeck, P. Postmus, and L. Tanoue, The Stage Classification of Lung Cancer, 191S-210S. 17. Hoboken, 2013.
DOI : 10.1378/chest.12-2354

F. Detterbeck, D. Boffa, and L. Tanoue, The New Lung Cancer Staging System, Chest, vol.136, issue.1, pp.260-71, 2009.
DOI : 10.1378/chest.08-0978

P. Postmus, E. Brambilla, and K. Chansky, The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer, Journal of Thoracic Oncology, vol.2, issue.8, pp.686-93, 2007.
DOI : 10.1097/JTO.0b013e31811f4703

URL : https://hal.archives-ouvertes.fr/inserm-00372201

P. Bonnette, Chirurgie des tumeurs pulmonaires de stade I. Cancer/Radiothérapie, 2011.

A. Krol, P. Aussems, E. Noordijk, J. Hermans, and J. Leer, Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation?, International Journal of Radiation Oncology*Biology*Physics, vol.34, issue.2, pp.297-302, 1996.
DOI : 10.1016/0360-3016(95)00227-8

K. Morita, N. Fuwa, Y. Suzuki, M. Nishio, K. Sakai et al., Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients, Radiotherapy and Oncology, vol.42, issue.1, pp.31-37, 1997.
DOI : 10.1016/S0167-8140(96)01828-2

F. Sirzen, E. Kjellen, S. Sorenson, and E. Cavallin-stahl, A Systematic Overview of Radiation Therapy Effects in Non-Small Cell Lung Cancer, Acta Oncologica, vol.56, issue.271, pp.5-6493, 2003.
DOI : 10.1093/jnci/86.9.673

J. Bradley, S. Wahab, M. Lockett, C. Perez, and J. Purdy, Elective nodal failures are uncommon in medically inoperable patients with Stage I non???small-cell lung carcinoma treated with limited radiotherapy fields, International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.2, pp.342-349, 2003.
DOI : 10.1016/S0360-3016(02)04614-X

F. Conforti, C. Catania, F. Toffalorio, M. Duca, G. Spitaleri et al., EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung, Lung Cancer, vol.81, issue.3, 2013.
DOI : 10.1016/j.lungcan.2013.05.019

H. Yu, C. Sima, J. Huang, S. Solomon, A. Rimner et al., Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, Journal of Thoracic Oncology, vol.8, issue.3, pp.346-51, 2013.
DOI : 10.1097/JTO.0b013e31827e1f83

A. Weickhardt, B. Scheier, J. Burke, G. Gan, X. Lu et al., Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer New techniques of tumor ablation (microwaves, electroporation), J Thorac Oncol. 2012 J Radiol, vol.792, issue.129, pp.1807-14789, 2011.

M. Riquet, C. Foucault, A. Cazeq, E. Mitry, A. Dujon et al., Pulmonary Resection for Metastases of Colorectal Adenocarcinoma, The Annals of Thoracic Surgery, vol.89, issue.2, pp.375-80, 2010.
DOI : 10.1016/j.athoracsur.2009.10.005

H. Koong, U. Pastorino, and R. Ginsberg, Is there a role for pneumonectomy in pulmonary metastases?, The Annals of Thoracic Surgery, vol.68, issue.6, pp.2039-2082, 1999.
DOI : 10.1016/S0003-4975(99)01151-0

F. Brenac, Traitement par radiofr??quence des tumeurs pulmonaires, Revue des Maladies Respiratoires Actualit??s, vol.2, issue.3, pp.247-51, 2010.
DOI : 10.1016/S1877-1203(10)70071-9

D. Lu, S. Raman, D. Vodopich, M. Wang, J. Sayre et al., Effect of Vessel Size on Creation of Hepatic Radiofrequency Lesions in Pigs, American Journal of Roentgenology, vol.178, issue.1, pp.47-51, 2002.
DOI : 10.2214/ajr.178.1.1780047

C. Vaughn, G. Mychaskiw, and P. Sewell, Massive Hemorrhage During Radiofrequency Ablation of a Pulmonary Neoplasm, Anesthesia & Analgesia, vol.94, issue.5, pp.1149-51, 2002.
DOI : 10.1097/00000539-200205000-00016

L. Herrera, H. Fernando, Y. Perry, W. Gooding, P. Buenaventura et al., Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates, The Journal of Thoracic and Cardiovascular Surgery, vol.125, issue.4, pp.929-966, 2003.
DOI : 10.1067/mtc.2003.18

C. Teriitehau, L. Tselikas, J. Potet, G. Farouille, F. Deschamps et al., Thermoablation par radiofréquence des lésions pulmonaires, Rev Mal Respir Actual, 2013.
DOI : 10.1016/s1877-1203(13)70447-6

T. Okuma, T. Okamura, T. Matsuoka, A. Yamamoto, Y. Oyama et al., Fluorine- 18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: Preliminary results, Annals of Nuclear Medicine, vol.28, issue.2, pp.115-136, 2006.
DOI : 10.1007/BF02985623

R. Mctaggart and D. Dupuy, Thermal ablation of lung tumors. Tech Vasc Interventional Rad, pp.102-115, 2007.

F. Bonichon, J. Palussière, Y. Godbert, M. Pulido, E. Descat et al., Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study, European Journal of Nuclear Medicine and Molecular Imaging, vol.18, issue.3, pp.1817-1844, 2013.
DOI : 10.1007/s00259-013-2521-9

T. De-baère, J. Palussière, A. Aupérin, A. Hakime, M. Abdel-rehim et al., Hospital: a review of 10 years of experience, Acta Med Okayama, vol.65, issue.43, pp.287-97, 2011.

F. Lévèque, N. Mazières, J. Auriol, J. Otal, P. Rousseau et al., minimum follow-up of 1 year: prospective evaluation. Radiology Chamming's Thermal ablation: tolerance and efficacy in a population mostly composed of primary lung cancers Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms, Midterm local efficacy and survival after radiofrequency ablation of lung tumors with, pp.587-96885, 2006.

R. Lencioni, L. Crocetti, R. Cioni, R. Suh, D. Glenn et al., Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study), The Lancet Oncology, vol.9, issue.7, pp.621-629, 2008.
DOI : 10.1016/S1470-2045(08)70155-4

C. Bolliger and A. Perruchoud, Functional evaluation of the lung resection candidate, European Respiratory Journal, vol.11, issue.1
DOI : 10.1183/09031936.98.11010198

A. Modesto, J. Giron, C. Massabeau, N. Sans, J. Berjaud et al., Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: Case report and review of the literature, Lung Cancer, vol.80, issue.3, pp.341-344, 2013.
DOI : 10.1016/j.lungcan.2013.02.003

J. Zhu, T. Yan, D. Morris, A. Hess, J. Palussière et al., A systematic review of radiofrequency ablation for lung tumors Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology, Ann Surg Oncol. Feb, vol.15258, issue.522, pp.1765-74635, 2008.

P. Mccormack, M. Bains, C. Begg, M. Burt, R. Downey et al., Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: Results of a prospective trial, The Annals of Thoracic Surgery, vol.62, issue.1, pp.213-219, 1996.
DOI : 10.1016/0003-4975(96)00253-6

T. Treasure, Pulmonary metastasectomy in colorectal cancer, British Journal of Surgery, vol.133, issue.Suppl 2, 2008.
DOI : 10.1002/bjs.9174

G. Friedel, U. Pastorino, M. Buyse, R. Ginsberg, P. Girard et al., Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases, Zentralblatt Für Chir, vol.124, issue.2, pp.96-103, 1999.

T. Chua, K. Thornbury, A. Saxena, W. Liauw, D. Glenn et al., Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases, pp.2106-2120, 2010.

A. Zemliak, H. Moore, and T. Bilfinger, Comparison of Survival after Sublobar Resections and Ablative Therapies for Stage I Non???Small Cell Lung Cancer, Journal of the American College of Surgeons, vol.211, issue.1, pp.37-4968, 2010.
DOI : 10.1016/j.jamcollsurg.2010.03.020

M. Ambrogi, O. Fanucchi, R. Cioni, P. Dini, D. Liperi et al., Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat Study, Journal of Thoracic Oncology, vol.6, issue.12, pp.2044-51, 2011.
DOI : 10.1097/JTO.0b013e31822d538d

T. Hiraki, H. Gobara, T. Iishi, Y. Sano, T. Iguchi et al., Percutaneous radiofrequency ablation for clinical stage I non???small cell lung cancer: Results in 20 nonsurgical candidates, The Journal of Thoracic and Cardiovascular Surgery, vol.134, issue.5, pp.1306-1318, 2007.
DOI : 10.1016/j.jtcvs.2007.07.013

C. Simon, D. Dupuy, T. Dipetrillo, H. Safran, C. Grieco et al., Pulmonary Radiofrequency Ablation: Long-term Safety and Efficacy in 153 Patients, Radiology, vol.243, issue.1, 2007.
DOI : 10.1148/radiol.2431060088

X. Li, M. Zhao, J. Wang, W. Fan, W. Li et al., Percutaneous CT-Guided Radiofrequency Ablation as Supplemental Therapy After Systemic Chemotherapy for Selected Advanced Non???Small Cell Lung Cancers, American Journal of Roentgenology, vol.201, issue.6, pp.1362-1369, 2013.
DOI : 10.2214/AJR.12.10511

S. Senan, D. Palma, and F. Lagerwaard, Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies, J Thorac Dis, vol.3, issue.3, pp.189-96, 2011.

S. Française-de-radiothérapie-oncologique, Guide des procédures de radiothérapie externe, 2007.

J. Zhang, F. Yang, B. Li, H. Li, J. Liu et al., Which Is the Optimal Biologically Effective Dose of Stereotactic Body Radiotherapy for Stage I Non???Small-Cell Lung Cancer? A Meta-Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.305-321, 2011.
DOI : 10.1016/j.ijrobp.2011.04.034

P. Lambin, Comparison of the effectiveness of radiotherapy with photons, protons and carbonions for non-small cell lung cancer: A meta-analysis, Radiother Oncol. 2010, vol.95, issue.1, pp.32-40

S. Gauden and L. Tripcony, The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population, Lung Cancer, vol.32, issue.1, pp.71-80, 2001.
DOI : 10.1016/S0169-5002(00)00199-9

N. Girard and F. Mornex, Radioth??rapie st??r??otaxique des cancers broncho-pulmonaires non ?? petites cellules??: d???un concept ?? une r??alit?? clinique. Actualit??s en 2011, Cancer/Radioth??rapie, vol.15, issue.6-7, pp.6-7522, 2011.
DOI : 10.1016/j.canrad.2011.07.241

M. Hatime, B. Elmorabit, Y. Elkhoti, S. Touch, R. Tanguy et al., Maladie oligom??tastatique, un nouveau concept??: irradiation en conditions st??r??otaxiques de m??tastases pulmonaires. Revue de la litt??rature, Cancer/Radioth??rapie, vol.16, issue.5-6, pp.5-6351, 2012.
DOI : 10.1016/j.canrad.2012.07.184

J. Warren, K. Yabroff, A. Meekins, M. Topor, E. Lamont et al., Evaluation of Trends in the Cost of Initial Cancer Treatment, JNCI Journal of the National Cancer Institute, vol.100, issue.12, pp.888-97, 2008.
DOI : 10.1093/jnci/djn175

J. Wisnivesky, E. Halm, M. Bonomi, C. Powell, and E. Bagiella, Effectiveness of Radiation Therapy for Elderly Patients with Unresected Stage I and II Non???Small Cell Lung Cancer, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.3, pp.264-273, 2010.
DOI : 10.1164/rccm.200907-1064OC

H. Liu, X. Zhang, Y. Vinogradskiy, S. Swisher, R. Komaki et al., Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.4, pp.1017-1040, 2012.
DOI : 10.1016/j.ijrobp.2012.02.020

M. Trovo, E. Minatel, E. Durofil, J. Polesel, M. Avanzo et al., Stereotactic Body Radiation Therapy for Re-irradiation of Persistent or Recurrent Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.5, pp.1114-1123, 2014.
DOI : 10.1016/j.ijrobp.2014.01.012

D. Palma, F. Lagerwaard, G. Rodrigues, C. Haasbeek, and S. Senan, Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.3, pp.1149-56, 2012.
DOI : 10.1016/j.ijrobp.2011.03.005

S. Stanic, R. Paulus, R. Timmerman, J. Michalski, R. Barriger et al., No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early- Stage Peripheral Non-Small Cell Lung Cancer: An Analysis of RTOG 0236, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.5, pp.1092-1101
DOI : 10.1016/j.ijrobp.2013.12.050

M. Guckenberger, R. Klement, L. Kestin, A. Hope, J. Belderbos et al., Lack of a Dose-Effect Relationship for Pulmonary Function Changes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.85, issue.4, pp.1074-81, 2013.
DOI : 10.1016/j.ijrobp.2012.09.016

R. Timmerman, B. Kavanagh, L. Cho, L. Papiez, and L. Xing, Stereotactic Body Radiation Therapy in Multiple Organ Sites, Journal of Clinical Oncology, vol.25, issue.8, pp.947-52, 2007.
DOI : 10.1200/JCO.2006.09.7469

D. Palma, O. Visser, F. Lagerwaard, J. Belderbos, B. Slotman et al., Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery, Radiotherapy and Oncology, vol.101, issue.2, pp.240-244, 2011.
DOI : 10.1016/j.radonc.2011.06.029

S. Senthi, F. Lagerwaard, C. Haasbeek, B. Slotman, S. Senan et al., Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy, Lancet Oncol. Department of Clinical Oncology Hong Kong Med J, vol.13, issue.88, pp.802-811, 1989.

É. Quoix, Les nouveautés épidémiologiques du cancer bronchique : les non-fumeurs, les femmes, les fumeurs de cannabis Rev Mal Respir Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group, BMJ, vol.24, issue.91, pp.10-15, 1995.

J. Sculier, M. Paesmans, J. Lafitte, J. Baumöhl, J. Thiriaux et al., A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy, Annals of Oncology, vol.10, issue.3, pp.295-303, 1999.
DOI : 10.1023/A:1008319506107

A. Trotti, A. Colevas, A. Setser, V. Rusch, D. Jaques et al., CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Seminars in Radiation Oncology, vol.13, issue.3, pp.176-81, 2003.
DOI : 10.1016/S1053-4296(03)00031-6

. Shuster, Median follow-up in clinical trials., Journal of Clinical Oncology, vol.9, issue.1, pp.191-193, 1991.
DOI : 10.1200/JCO.1991.9.1.191

E. Quoix and E. Lemarié, ??pid??miologie du cancer bronchique primitif??: aspects classiques et nouveaut??s, Revue des Maladies Respiratoires, vol.28, issue.8, pp.1048-58, 2011.
DOI : 10.1016/j.rmr.2010.12.015

L. Thiberville and C. Paris, Épidémiologie et facteurs de risque des cancers bronchiques primitifs. EMC -Pneumol, pp.7-18, 2004.

B. Johnson, Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer, JNCI Journal of the National Cancer Institute, vol.90, issue.18, pp.1335-1380, 1998.
DOI : 10.1093/jnci/90.18.1335

H. Kodama, K. Yamakado, H. Takaki, M. Kashima, J. Uraki et al., Lung Radiofrequency Ablation for the Treatment of Unresectable Recurrent Non-Small-Cell Lung Cancer After Surgical Intervention, CardioVascular and Interventional Radiology, vol.122, issue.3, pp.563-572
DOI : 10.1007/s00270-011-0220-0

T. Hiraki, J. Sakurai, T. Tsuda, H. Gobara, Y. Sano et al., Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors. Cancer, 2006.

M. Beland, E. Wasser, W. Mayo-smith, and D. Dupuy, Primary Non???Small Cell Lung Cancer: Review of Frequency, Location, and Time of Recurrence after Radiofrequency Ablation, Radiology, vol.254, issue.1, pp.301-308, 2010.
DOI : 10.1148/radiol.00000090174

H. Lee, G. Jin, Y. Han, G. Chung, Y. Lee et al., Comparison of Survival Rate in Primary Non-Small-Cell Lung Cancer Among Elderly Patients Treated With Radiofrequency Ablation, Surgery, or Chemotherapy, CardioVascular and Interventional Radiology, vol.116, issue.9, 2012.
DOI : 10.1007/s00270-011-0194-y

P. Mordant, P. Pages, C. Foucault, A. Badia, E. Fabre et al., Chirurgie des cancers bronchopulmonaires apr??s traitement d???un premier cancer, Revue des Maladies Respiratoires, vol.30, issue.5, 2013.
DOI : 10.1016/j.rmr.2013.01.005

C. Azzoli, S. Temin, T. Aliff, S. Baker, J. Brahmer et al., Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non?Small-Cell Lung Cancer, Focused Update J Clin Oncol, 2009.

L. Paz-ares, F. De-marinis, M. Dediu, M. Thomas, J. Pujol et al., Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial, The Lancet Oncology, vol.13, issue.3, pp.247-55, 2012.
DOI : 10.1016/S1470-2045(12)70063-3